Innovative Solutions for Life Science Founders
Discover cutting-edge solutions and services to advance your organization
Innovative Solutions for Life Science Founders
Discover cutting-edge solutions and services to advance your organization
Discover cutting-edge solutions and services to advance your organization
Discover cutting-edge solutions and services to advance your organization
We specializing in innovative bespoke solutions and strategies for healthcare and biotech organizations around the world.
With a strong focus on US and European markets and long term partnerships in emerging markets.
In a world brimming with ingenuity and creativity, we stand as a catalyst for progress, bridging the gap between groundbreaking ideas and their transformative impact on society. We are a global organization, united by a shared passion to nurture next-generation innovations and shepherd them to fruition.
With decades of combined experience in strategy and drug development, go to market strategy and execution, our team has the expertise and network to bring innovation to life.
We are a collective of visionary minds, united by a shared passion to transform the world through groundbreaking ideas. Our founders are the cornerstone of our innovation, the driving force behind our success.
We help founders build relationships with key partners and investors, develop bespoke strategies, and provide business development needed to bring their product from early development to market.
We empower founders to create therapies, products, and services that save lives in our innovation labs based in the US and Europe.
We collaborate with innovative biotech/pharma companies and founders to translate their groundbreaking ideas into thriving businesses by offering them the necessary resources, and support to navigate the entrepreneurial journey.
Ross Marshall is a highly accomplished strategist known for his expertise in designing, building, and leading scalable equity-focused programs and initiatives for complex organizations.
Ross graduated from Bates College with a major in Geology. and minor in Chemistry, and from the Harvard Business School.
Ross is reno
Ross Marshall is a highly accomplished strategist known for his expertise in designing, building, and leading scalable equity-focused programs and initiatives for complex organizations.
Ross graduated from Bates College with a major in Geology. and minor in Chemistry, and from the Harvard Business School.
Ross is renowned for his ability to articulate a compelling vision, translating it into actionable strategies, and rally cross-functional partnerships and teams to deliver exceptional outcomes in alignment with their core mission. With a proven track record of driving transformative change, he brings unparalleled expertise in executing high-impact initiatives that propel organizations to new levels of success.
Nicolas PM Breuer is a confirmed expert and leader in BD&L, Alliances with extensive general management experience in pharmaceuticals all over the globe.
Nicolas is a graduate of the Royal Navy Academy and Royal Defense College from Belgium, as well as of the Solvay Business School and Harvard Business School.
Nicolas
Nicolas PM Breuer is a confirmed expert and leader in BD&L, Alliances with extensive general management experience in pharmaceuticals all over the globe.
Nicolas is a graduate of the Royal Navy Academy and Royal Defense College from Belgium, as well as of the Solvay Business School and Harvard Business School.
Nicolas is known for his ability to find the right approaches and strategies to make the best of your assets in difficult and complex markets, regulatory environments and competitive landscapes.
Nicolas is married, loves taking care of kids and is seen as a real humanist.
Cliff Harrison is a seasoned strategist and General Partner at Bio Venture Group (BVG), a leading venture firm dedicated to fostering innovation and growth in the life sciences sector. He brings a wealth of expertise in designing and leading scalable solutions for complex organizations.
Cliff's extensive background spans various industries, including commercial real estate, where he held the position of Commercial Real Estate Broker at Cushman and Wakefield and JLL. In this role, he excelled at managing portfolios, developing new business opportunities, and providing brokerage services for clients across Greater Boston and internationally. His proven track record of success in strategic planning, business development, and relationship building aligns seamlessly with BVG's mission to identify and support groundbreaking life sciences ventures.
Prior to joining BVG, Cliff served as the Member Benefits Consultant of Edge Programs at MassBio. In this capacity, he played a pivotal role in ensuring that member companies benefited from best-in-market pricing, pre-negotiated discounts, rebates, and incentives through MassBio's Edge Preferred Partners program. This experience further solidified his understanding of the intricate dynamics within the life sciences ecosystem and the importance of fostering collaboration and value creation.
Cliff's educational background complements his professional accomplishments. He holds a Bachelor of Science degree in Business Management from Northeastern University's College of Professional Studies. This rigorous academic foundation has provided him with a strong understanding of business principles and financial acumen, which are essential for success in the venture capital arena.
Beyond his professional endeavors, Cliff is deeply committed to giving back to his community. He currently serves on the board of his middle school alma mater, Nativity Preparatory School, an all-boys Jesuit middle school in Jamaica Plain. This dedication to community service reflects his personal values and underscores his commitment to making a positive impact beyond the realm of business.
As Cliff joins BVG's team of seasoned investors, he brings a unique blend of strategic expertise, industry knowledge, and a passion for driving innovation. His appointment reinforces BVG's position at the forefront of life sciences venture capital, further solidifying its commitment to supporting promising companies that are shaping the future of healthcare.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.